Escherichia coli
E. coli
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A normal inhabitant of the human gut and the most common cause of urinary tract infection. Extraintestinal strains cause cystitis, pyelonephritis and bloodstream infection; separate diarrheagenic strains cause gastrointestinal illness (see Diarrheagenic E. coli).
Infections
Cystitis, pyelonephritis, urosepsis, intra-abdominal infection, bloodstream infection, neonatal meningitis.
Signs and symptoms
Urinary: dysuria, frequency, urgency, suprapubic or flank pain, fever. Bloodstream infection: fever, rigors, hypotension.
Antibiotic and antimicrobial resistance
Extended-spectrum beta-lactamases (CTX-M, SHV, TEM) (ESBL genes) are increasingly common; carbapenemases (carbapenemases) and plasmid-mediated quinolone resistance (qnr) also occur.
Treatment considerations
Uncomplicated cystitis is commonly treated with nitrofurantoin, trimethoprim-sulfamethoxazole or fosfomycin, chosen by local resistance rates. Pyelonephritis and systemic infection need agents with tissue and blood levels, guided by susceptibility testing; ESBL-producing strains often require a carbapenem.

Sources
- CDC. E. coli infection.
- CDC. ESBL-producing Enterobacterales.
- IDSA. Complicated Urinary Tract Infections guideline.
- IDSA. Asymptomatic Bacteriuria guideline.
- IDSA. Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.